Cafepharma Today

June 23 2025 - Illumina bets on proteomics with $425m SomaLogic purchase
Illumina bets on proteomics with $425m SomaLogic purchase
Acting CDER head becomes latest in string of FDA leaders to leave agency
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 28%
Roche's Hemlibra follow-up set for phase 3 in hemophilia A
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Yahoo/Benzinga
Tuesday, November 19, 2024 - 7:09pm
tags:
Bristol Myers Squibb, ACR, clinical trials, autoimmune disease
Prostate cancer: Three drug trials to watch
Clinical Trials Arena
Tuesday, November 19, 2024 - 11:22am
tags:
prostate cancer, clinical trials, Candel Therapeutics, ProstAtak, JNJ, Akeega, Pfizer, Mevrometostat
Bayer lands regional rights to aficamten in Japan deal with Cytokinetics
First Word Pharma
Tuesday, November 19, 2024 - 11:20am
tags:
Bayer, Japan, Cytokinetics, aficamten, hypertrophic cardiomyopathy
GSK scratches itch for phase 3 win, hitting goal in liver disease trial to open up untapped market
Fierce Biotech
Tuesday, November 19, 2024 - 11:18am
tags:
GSK, linerixibat, liver disease, clinical trials
Merck says Keytruda injection on par with approved IV version in trial
CNBC
Tuesday, November 19, 2024 - 11:17am
tags:
Merck, Keytruda, IVs
Lilly's lipoprotein-blocking heart med posts midstage win, turning up heat on potential AZ showdown
Fierce Biotech
Tuesday, November 19, 2024 - 11:16am
tags:
Eli Lilly, lipoproteins, clinical trials, cholesterol, muvalaplin
Astellas CRL ‘clearly a positive’ for Apellis, says JPMorgan
Tip Ranks
Tuesday, November 19, 2024 - 11:13am
tags:
Astellas, Apellis, FDA, geographic atrophy, Izervay, Syfovre
Toragen reports positive results from trial of TGN-S11 for HPV-related cancer
Clinical Trials Arena
Tuesday, November 19, 2024 - 11:10am
tags:
Toragen, TGH-S11, HPV, clinical trials
Nationwide IV fluid shortage changing how hospitals manage patient hydration
NPR
Tuesday, November 19, 2024 - 11:05am
tags:
IVs, Medtech, shortages
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
Clinical Trials Arena
Tuesday, November 19, 2024 - 11:00am
tags:
JNJ, clinical trials, JNJ-2113, psoriasis
Future of Medicare drug price negotiations under new administration: 5 things to know
Beckers Hospital Review
Tuesday, November 19, 2024 - 10:59am
tags:
Medicare, Inflation Reduction Act, drug pricing, Donald Trump
What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
Pharma Voice
Tuesday, November 19, 2024 - 10:57am
tags:
AbbVie, R&D, virology
Abbott opens new FreeStyle Libre manufacturing plant in Ireland
Mass Device
Monday, November 18, 2024 - 6:44pm
tags:
Abbott Labs, Medtech, Ireland, FreeStyle Libre, diabetes
Sanofi lays out €40M to beef up transplant, diabetes drug production in France
Fierce Pharma
Monday, November 18, 2024 - 6:37pm
tags:
Sanofi, diabetes, type 1 diabetes, France, drug manufacturing
Eisai sunsets development, access program for withdrawn obesity med in Dravet syndrome
Fierce Pharma
Monday, November 18, 2024 - 6:36pm
tags:
Eisai, obesity, lorcaserin
FDA endorses speedy approval path for Regenxbio Duchenne gene therapy
BioPharma Dive
Monday, November 18, 2024 - 6:32pm
tags:
Rengexbio, DMD, gene therapy, FDA, RGX-202
Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
Clinical Trials Arena
Monday, November 18, 2024 - 6:30pm
tags:
Alnylam Pharmaceuticals, nucresiran, RNAi, clinical trials
Novartis, Ratio sign radiopharmaceutical pact to the tune of $745M biobucks
Fierce Biotech
Monday, November 18, 2024 - 11:32am
tags:
Novartis, radiopharmaceuticals, Ration Therapeutics, biobucks
Intellia’s gene editing therapy shows early potential in rare heart condition
Clinical Trials Arena
Monday, November 18, 2024 - 11:30am
tags:
Intellia, gene editing, NTLA-2001, AHA, ATTR-CM
Novo’s Wegovy Launched in China at a Fraction of US Price
BioSpace
Monday, November 18, 2024 - 11:28am
tags:
Novo Nordisk, Wegovy, Cina, weight loss, GLP-1 agonists

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.